Oracle shares dropped about 5% after the company filed to raise $20 billion in new equity and debt, reviving investor concern over how the AI buildout is financed.
- Oracle filed to sell $10B of common stock and $10B of senior notes on Monday, Nov. 2, 2026.
- Shares fell more than 5% and are down about 33% in 2026 and roughly 50% over 12 months.
- The raise uses the full $20B cap set for fiscal 2027-2030, excluding refinancing.
Lead
Oracle (NYSE: ORCL) fell more than 5% on Monday after filing with the Securities and Exchange Commission to sell $10 billion of common stock and $10 billion of senior notes. The proceeds are earmarked for general corporate purposes, including data centers for AI customers such as OpenAI and the repayment of existing debt. The offering lifted concerns about leverage at one of the most heavily indebted AI stocks, pushing the shares to roughly 33% lower for the year.What Did Oracle File To Sell?
Oracle filed to sell a combined $20 billion of new capital, split evenly between equity and investment-grade debt. The $10 billion stock sale dilutes existing shareholders, while the $10 billion bond sale adds to a debt load that has been a central point of debate since the company began committing tens of billions of dollars to cloud and AI infrastructure.
The size was not a surprise. Management had capped new capital-markets funding for fiscal 2027 to 2030 at $20 billion at an investor day held days earlier. The filing uses that allowance in full at the outset.
Why Did Oracle Shares Fall Despite the Investor Day Rally?
Shares fell because the filing converted a stated funding limit into an immediate, dilutive transaction. The stock had jumped about 12% after the investor day, when Oracle reaffirmed fiscal 2030 targets of more than $225 billion in revenue, $21 in earnings per share and a new 40% operating margin goal. It also reaffirmed fiscal 2027 guidance of at least $90 billion in revenue and $8.10 in EPS.
Selling stock and bonds on the same day gave back part of that gain. Equity issuance weighs on the share price directly, and a simultaneous bond deal underscores that the buildout is still being financed externally. Investors have watched Oracle stock and bonds come under pressure for months as borrowing to build data centers raised the company's leverage.
How Does Oracle Plan To Fund the Rest of Its AI Buildout?
Oracle intends to cover the remaining capital needs through vendor financing, customer prepayments and customer-supplied hardware rather than additional public-market issuance. Examples cited include financing from chip suppliers such as Nvidia (NVDA) and arrangements in which OpenAI pays for GPUs directly.
The company plans to add roughly 7 gigawatts of AI data-center capacity, taking the total to about 10 gigawatts by fiscal 2028. Capital spending is expected to peak across fiscal 2027 and 2028. Management forecast positive free cash flow in the second half of fiscal 2028 and more than $30 billion in fiscal 2029.
Market Reaction and AI Debt Concerns
The selloff reflects a wider question about whether AI infrastructure spending can be funded without straining balance sheets. Oracle is a focal point because its commitments to OpenAI are large relative to its size, and its customer base for the new capacity is concentrated.
The reaction was contained to the issuer and its AI-linked peers. Shares of CoreWeave (CRWV) edged higher, while Microsoft (MSFT) held steady, suggesting investors were treating the move as Oracle-specific rather than a sector-wide repricing. The stock's 50% decline over 12 months means the new equity is being sold at a much lower price than a year ago, which raises the dilution cost per dollar raised.
What Comes Next for Oracle?
The next test is execution. Pricing of the bond tranche and the stock offering will show how much demand exists for Oracle paper at current valuations. Beyond that, the focus shifts to whether customer prepayments and vendor financing arrive on schedule, and whether free cash flow turns positive in the second half of fiscal 2028 as guided.
If funding stays within the $20 billion cap, the company's leverage trajectory will be the main variable for credit investors. Any move to exceed the cap would contradict the framework presented at the investor day.
Outlook
Oracle has used its full external funding allowance at the start of the fiscal 2027-2030 cycle, trading near-term dilution for balance-sheet room to build capacity for OpenAI and other customers. The shares, down about 33% this year, will trade on execution of the buildout and delivery of the free cash flow targets, while the broader market continues to weigh how much debt the AI buildout can carry.
Mentioned tickers: ORCL, NVDA, MSFT, CRWV




